2 September 2010

Enfis Group

SPECULATIVE BUY

26/08/2008 James Crux

Environmental and political pressures, only heightened by the current high oil price, are fuelling growth at LED array designer and maker Enfis, whose products offer power and carbon footprint benefits.

Against the backdrop of global legislative drives to accelerate the replacement of traditional lighting with LEDs – highly reliable, energy efficient, offering longevity and safe disposability characteristics – Enfis is seeing particularly strong demand for its ‘straight from the box’ light engine solutions from the fastest growing Solid State Lighting (SSL) markets, namely architectural, retail and entertainment.

Technology entrepreneur Shaun Oxenham, CEO, who says ‘we are an organic growth story in a fast-growing market’, recently unveiled encouraging interim figures to June from Enfis. Though losses widened from £891,000 to almost £1.1m, there was 300% growth in sales to £392,000, admittedly from a low base.

However, contract momentum is gathering, supporting the ambitious forecasts of analysts. In July, Enfis announced a contract to provide light engines to a mystery ‘tier-one’ lighting company, for a Middle East project in the hospitality sector, a deal awarded ahead of major international competitors.

This followed a deal for the supply of light engines to Chinese digital medical equipment group CTMC for the retrofit of its operating theatre lighting products with LEDs.

While pre-tax losses of £1.9m from £1.5m sales are predicted this year, a small profit from a top line £6m is envisioned by December 2009.

Given growing interest in the group’s technology, cash balances of more than £1m at the halfway stage and Oxenham’s insistence the business model is both scalable and cash generative, we think Enfis offers longer-term speculative appeal.

Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.

Sector: Electronic & Electrical Equipment

Companies: Enfis

Market cap: £7.74m

PE Forecast: n/a

Share price: 82.5p

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

Delcam 01/09/2010

Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.

Antisoma 01/09/2010

Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.

GW Pharmaceuticals 31/08/2010

GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.

More Recommendations

Sectors

Vitesse Media Events